Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria - which can have a devastating impact on tens of thousands of children who are admitted to hospital with severe malaria every year.

Anopheles mosquito

The new paper, Malaria infection and severe disease risks in Africa,  key conclusions included:

  • If we can reduce malaria transmission by a quarter we can halve the rate of children needing emergency care for severe, life-threatening malaria.
  • Supports the current intervention policies - that are focusing on younger children - as the most effective strategy for preventing severe malaria disease.
  • Help in understanding and predicting the age-pattern at which children are hospitalised under different settings, so resources can be focused on the children with the highest risk of needing emergency care.

The research, published in Science, analysed over 6000 paediatric hospital admissions from 35 hospitals across Africa, matching patients to populations where the chances of childhood infection varied from very low to very high. They looked for typical indicators of severe disease in children, including anaemia, cerebral symptoms, and respiratory distress.

Read the full story on the University of Oxford website

Similar stories

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

Athena Swan Gold Award success for Nuffield Department of Primary Care Health Sciences

The award reflects the Department’s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.

RECOVERY trial team awarded MRC Impact Prize for Outstanding Team Impact

The Medical Research Council Prize Committee has awarded the RECOVERY trial team the MRC Impact Prize 2022 for Outstanding Team Impact.

Professor Sir Chris Whitty brings greater understanding of epidemics to Oxford

Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.

Multiple Debilitating Pains – New global study shows the experience of Endometriosis is rooted in a person’s genetics

Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.

Study shows delaying treatment for localised prostate cancer does not increase mortality risk

Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.